Acciones de Stryker Corp. (SYK) — ¿es un buen negocio?

Acciones de Stryker Corp. (SYK) — ¿es un buen negocio? — InspectStocks

Just reported

Q3 2026 results

From Stryker's results release of 29 de octubre de 2026; its quarterly report has since been filed.

Revenue
Actual
6,52B US$
+7,6 % y/y
-1,0 % q/q
Guided
—
No guide given
EPS, GAAP
Actual
1,96 US$
-12 % y/y
-41 % q/q
Guided
—
No guide given
Operating income, GAAP
Actual
1,03B US$
-8,9 % y/y
-38 % q/q
Guided
—
No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

The full earnings report →

Cómo gana dinero

MedSurg and Neurotechnology products55 %
Orthopaedics products45 %

Los porcentajes de ingresos son estimaciones para nine months ended 2026-09-30, no cifras de un informe oficial.

Compite con

Qué vende6

Surgical instruments and navigation systems
Powered surgical tools and navigation equipment that help surgeons carry out procedures.
Endoscopy and communications equipment
Cameras and related equipment that let clinicians view inside the body, alongside systems that connect operating-room equipment.
Patient and emergency-care equipment
Hospital beds, patient-handling equipment, emergency monitors and defibrillators, intensive-care disposables, and clinician communication systems.

Mostrar 3 más

Minimally invasive vascular devices
Catheters and other devices used in minimally invasive treatment of stroke and venous blood clots.
Brain and cranial surgery products
Products for brain and open-skull surgery, including synthetic bone grafts and products used to treat spinal bone conditions.
Joint and trauma implants and robotic surgery systems
Hip, knee, shoulder, ankle and trauma implants, plus robotic systems and surgical tools used in these operations.

Quién se lo compra4

Hospitals and health systems buy operating-room, patient-care, emergency and communication equipment, often directly from Stryker.
Surgeons and other physicians select implants, instruments and procedural devices for operations; hospitals or other healthcare facilities are often the paying buyers.
Emergency medical services providers and other healthcare facilities buy emergency-care equipment.
Third-party dealers and distributors buy or resell products to healthcare providers.

En qué se apoya y qué podría romperlo

De qué depende el negocio

1Some raw materials are sourced from single suppliers, so supply interruptions could affect manufacturing.
2The business depends on medical-device approvals, clinical testing and ongoing compliance with United States and foreign regulations.
3Sales depend on hospitals' and healthcare providers' ability and willingness to buy equipment, and on procedure volumes, pricing and reimbursement.

Qué podría salir mal

1A cybersecurity incident in the first quarter of 2026 disrupted operations and production; system recovery, security work and related costs remain exposures.
2Supply constraints at a plant serving the Peripheral Vascular business caused backorders and lost sales; the business's operating outlook has also been affected by supply and market conditions.
3Medical-device approval and quality rules can delay products or require costly changes, while product recalls, liability claims and healthcare cost controls can affect sales and costs.

Estados financieros completos →

Sobre Stryker Corp.

Stryker makes equipment used during operations and in hospital wards, including cameras, surgical instruments, beds, emergency devices and systems that help hospital staff communicate. It also makes minimally invasive devices to treat strokes and blood clots, plus implants and robotic systems used in joint replacement and trauma surgery. It sells mainly to doctors, hospitals and other healthcare facilities, both directly and through distributors.

Sede: Kalamazoo, Michigan, United States
Fundada en: 1941
Empleados: approximately 56,000 (2025-12-31, high)
Cotiza en: NYSE
Cierre del ejercicio: December 31

Construido a partir de los propios informes de Stryker Corp. ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.

Just reported

Q3 2026 results

From Stryker's results release of 29 de octubre de 2026; its quarterly report has since been filed.

Revenue
Actual
6,52B US$
+7,6 % y/y
-1,0 % q/q
Guided
—
No guide given
EPS, GAAP
Actual
1,96 US$
-12 % y/y
-41 % q/q
Guided
—
No guide given
Operating income, GAAP
Actual
1,03B US$
-8,9 % y/y
-38 % q/q
Guided
—
No guide given

The full earnings report →

Keep exploring

The themes Stryker is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Highest-graded in Medical Devices

Graded A or B and worth $2B or more: A first, then the largest.

All 132 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises